Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J4MY
|
||||
Former ID |
DCL000333
|
||||
Drug Name |
Tasidotin hydrochloride
|
||||
Synonyms |
Tasidotin HCl; BSF 223651; ILX 651; LU 223651; Tasidotin hydrochloride (USAN)
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [528421] | ||
Company |
Genzyme
|
||||
Structure |
Download2D MOL |
||||
Formula |
C32H59ClN6O5
|
||||
Canonical SMILES |
CC(C)C(C(=O)N(C)C(C(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC<br />(C)(C)C)NC(=O)C(C(C)C)N(C)C.Cl
|
||||
InChI |
1S/C32H58N6O5.ClH/c1-19(2)24(33-28(40)25(20(3)4)35(10)11)30(42)36(12)26(21(5)6)31(43)38-18-14-16-23(38)29(41)37-17-13-15-22(37)27(39)34-32(7,8)9;/h19-26H,13-18H2,1-12H3,(H,33,40)(H,34,39);1H/t22-,23-,24-,25-,26-;/m0./s1
|
||||
InChIKey |
OOKIODJYZSVHDO-QMYFOHRPSA-N
|
||||
CAS Number |
CAS 623174-20-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Binder | [536891] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.